Atherectomy Devices Global Market, By Product & Data Validation, 2016 Analysis and Forecast 2022
ReportsWeb.com published “Atherectomy Devices Global Market” from its database. This report Strategic recommendations in key business segments based on the market estimations. This report Supply chain trends mapping the latest technological advancements.
(EMAILWIRE.COM, December 06, 2017 ) According to Publisher, the Global Atherectomy Devices market is accounted for $496.54 million in 2016 and is expected to reach $812.35 million by 2022 growing at a CAGR of 8.6% during the forecast period 2016 to 2022. High prevalence of Peripheral Artery Disease (PAD) across the globe is creating opportunities in the present market scenario. The market is presently consumed by demand for Minimally Invasive Surgeries (MIS). The lesser consequences of traumas across patients and quicker recovery than other procedures are acting as drivers for the market of Atherectomy Devices.
For more information about this report: http://www.reportsweb.com/atherectomy-devices-global-market-outlook-2016-2022
Rotational Atherectomy device segment is expected to dominate the market over the forecast period. Favorable reimbursement scenario is attributing the market towards growth. North America market is expected to dominate the regional segment on account of high number of approved FDA devices and suitable reimbursement scenario. Moreover, Asia Pacific is expected to grow at highest CAGR, prevailing to socio-economic changes and growing number of geriatric population.
Some of the key players of the Atherectomy Devices market include Abbott Laboratories, Avinger Inc., Bayer AG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health (Cordis), Cardiovascular Systems Inc., Cordis Corporation (Subsidiary of J&J), Covidien, Medtronic plc., Spectranetics, ST. Jude Medical, Straub Medical AG, Terumo Medical Corporation and Volcano Corporation
Technologies Covered:
-Directional Atherectomy Devices
-Laser Atherectomy Devices
-Orbital Atherectomy Devices
-Rotational Atherectomy Sevices
Disease Sites covered:
-Coronary artery disease
-Peripheral artery disease
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001716626/sample
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of APAC
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Company Profiling
9.1 Abbott Laboratories
9.2 Avinger Inc.
9.3 Bayer AG
9.4 Boston Scientific Corporation
9.5 C. R. Bard, Inc.
9.6 Cardinal Health (Cordis)
9.7 Cardiovascular Systems Inc.
9.8 Cordis Corporation (Subsidiary of J&J)
9.9 Covidien
9.10 Medtronic plc.
9.11 Spectranetics
9.12 ST. JUDE MEDICAL
9.13 Straub Medical AG
9.14 Terumo Medical Corporation
9.15 VOLCANO CORPORATION
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001716626/buying
For more information about this report: http://www.reportsweb.com/atherectomy-devices-global-market-outlook-2016-2022
Rotational Atherectomy device segment is expected to dominate the market over the forecast period. Favorable reimbursement scenario is attributing the market towards growth. North America market is expected to dominate the regional segment on account of high number of approved FDA devices and suitable reimbursement scenario. Moreover, Asia Pacific is expected to grow at highest CAGR, prevailing to socio-economic changes and growing number of geriatric population.
Some of the key players of the Atherectomy Devices market include Abbott Laboratories, Avinger Inc., Bayer AG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health (Cordis), Cardiovascular Systems Inc., Cordis Corporation (Subsidiary of J&J), Covidien, Medtronic plc., Spectranetics, ST. Jude Medical, Straub Medical AG, Terumo Medical Corporation and Volcano Corporation
Technologies Covered:
-Directional Atherectomy Devices
-Laser Atherectomy Devices
-Orbital Atherectomy Devices
-Rotational Atherectomy Sevices
Disease Sites covered:
-Coronary artery disease
-Peripheral artery disease
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001716626/sample
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of APAC
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Company Profiling
9.1 Abbott Laboratories
9.2 Avinger Inc.
9.3 Bayer AG
9.4 Boston Scientific Corporation
9.5 C. R. Bard, Inc.
9.6 Cardinal Health (Cordis)
9.7 Cardiovascular Systems Inc.
9.8 Cordis Corporation (Subsidiary of J&J)
9.9 Covidien
9.10 Medtronic plc.
9.11 Spectranetics
9.12 ST. JUDE MEDICAL
9.13 Straub Medical AG
9.14 Terumo Medical Corporation
9.15 VOLCANO CORPORATION
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001716626/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results